ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
0.567
+0.042 (8.04%)
Nov 20, 2024, 4:00 PM EST - Market closed

ABVC BioPharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
0.140.060.095.834.270.14
Upgrade
Short-Term Investments
0.070.080.080.11--
Upgrade
Cash & Short-Term Investments
0.210.140.165.944.270.14
Upgrade
Cash Growth
-63.39%-13.41%-97.29%38.93%2861.44%-36.35%
Upgrade
Accounts Receivable
0.010.010.860.430.30.31
Upgrade
Other Receivables
1.2---0.120.12
Upgrade
Receivables
1.220.761.370.430.850.64
Upgrade
Inventory
---0.03--
Upgrade
Prepaid Expenses
0.090.10.150.530.170.08
Upgrade
Restricted Cash
0.630.661.310.740.730.02
Upgrade
Other Current Assets
----0.150
Upgrade
Total Current Assets
2.151.662.997.656.170.88
Upgrade
Property, Plant & Equipment
8.448.781.7422.291.05
Upgrade
Long-Term Investments
2.332.530.840.931.193.36
Upgrade
Long-Term Deferred Tax Assets
--0.120.981.791.46
Upgrade
Other Long-Term Assets
1.541.533.151.590.160.18
Upgrade
Total Assets
14.4614.499.5813.711.616.93
Upgrade
Accounts Payable
----0.020.02
Upgrade
Accrued Expenses
3.633.262.441.32.122.03
Upgrade
Short-Term Debt
0.870.921.911.872.122.38
Upgrade
Current Portion of Long-Term Debt
0.950.720.34-0.252.02
Upgrade
Current Portion of Leases
0.370.40.370.350.320.3
Upgrade
Current Income Taxes Payable
-0.11----
Upgrade
Current Unearned Revenue
0.080.080.010.010.010.01
Upgrade
Other Current Liabilities
0.420.440.470.170.010.05
Upgrade
Total Current Liabilities
6.325.935.543.694.846.81
Upgrade
Long-Term Debt
----2.62-
Upgrade
Long-Term Leases
0.140.410.791.121.460.24
Upgrade
Other Long-Term Liabilities
0.030.020.010.010.020
Upgrade
Total Liabilities
6.486.366.344.838.947.05
Upgrade
Common Stock
0.010.0100.030.020.02
Upgrade
Additional Paid-In Capital
87.3182.6467.9458.1140.7528.18
Upgrade
Retained Earnings
-70.55-65.42-54.9-38.48-25.64-15.85
Upgrade
Treasury Stock
-8.9-8.9-9.1-9.1-9.1-9.1
Upgrade
Comprehensive Income & Other
0.490.06-0.84-1.72-2.6-3.4
Upgrade
Total Common Equity
8.368.393.18.843.44-0.15
Upgrade
Minority Interest
-0.38-0.260.140.03-0.780.03
Upgrade
Shareholders' Equity
7.988.133.248.872.66-0.12
Upgrade
Total Liabilities & Equity
14.4614.499.5813.711.616.93
Upgrade
Total Debt
2.332.453.413.346.764.94
Upgrade
Net Cash (Debt)
-2.12-2.31-3.252.6-2.49-4.79
Upgrade
Net Cash Per Share
-0.21-0.53-1.031.04-1.26-2.74
Upgrade
Filing Date Shares Outstanding
12.4110.533.2832.411.92
Upgrade
Total Common Shares Outstanding
12.417.913.262.872.411.92
Upgrade
Working Capital
-4.17-4.28-2.563.961.33-5.94
Upgrade
Book Value Per Share
0.671.060.953.091.42-0.08
Upgrade
Tangible Book Value
8.368.393.18.843.44-0.15
Upgrade
Tangible Book Value Per Share
0.671.060.953.091.42-0.08
Upgrade
Land
-0.360.360.40.40.37
Upgrade
Buildings
-2.232.232.242.232.23
Upgrade
Machinery
-1.311.291.211.181.17
Upgrade
Construction In Progress
-7.4----
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.